Detection of bone marrow micrometastases in patients with primaiy breast câncer: correlations with pTNM stage, age and histological grade

Authors

  • Tereza sollero claudio da-Silva Hospitais Universitários Moncorvo Filho e clementino Fraga Filho, da Universidade Federal do Rio de laneiro (UFR|), e Banco de Células do Programa Avançado de Biologia Celular Aplicado à Medicina do HUCFF/UFR|.
  • Rosane Bizon Hospitais Universitários Moncorvo Filho e clementino Fraga Filho, da Universidade Federal do Rio de laneiro (UFR|), e Banco de Células do Programa Avançado de Biologia Celular Aplicado à Medicina do HUCFF/UFR|.
  • Maria Helena Nicola Hospitais Universitários Moncorvo Filho e clementino Fraga Filho, da Universidade Federal do Rio de laneiro (UFR|), e Banco de Células do Programa Avançado de Biologia Celular Aplicado à Medicina do HUCFF/UFR|.
  • Radovan Borojevic Hospitais Universitários Moncorvo Filho e clementino Fraga Filho, da Universidade Federal do Rio de laneiro (UFR|), e Banco de Células do Programa Avançado de Biologia Celular Aplicado à Medicina do HUCFF/UFR|.
  • Maurício Magalhães Costa Hospitais Universitários Moncorvo Filho e clementino Fraga Filho, da Universidade Federal do Rio de laneiro (UFR|), e Banco de Células do Programa Avançado de Biologia Celular Aplicado à Medicina do HUCFF/UFR|.

Keywords:

Breast cancer, Post-surgical stage, Bone marrow, Micrometastases

Abstract

As the early occu/t dissemination of tumor cells is one ofthe major causes of relapse after
local treatment, the detection of epithellal cells (micrometastases) in the bone marrow of
breast câncer patients may have prognostic implications. The aim of th is study was to detect
micrometastases in bone marrow, using a molecular bioiogicai method, immunocytochemestry,
and correlate them with prognosis and other clinicai and pathological features on the seiected
patients. Bone marrow aspiration was obtained from 37patients at stages I, II or IIIA, already
with indication of surgery treatment. Bone marrow punch was performed in anterior iiiac crest,
immediately before the breast câncer operation, and stored in heparin-treated tubes. For the
immunocytochemical anaiysis we use d monoclonal antibody pancytokeratin. Our results show
sensitivity and specificity for immunocythemicai techniques. The presence of micrometastases
positive cases induded 23.6% of the patients without and 72.2% of those with lymph node
metastases. We conduded that the presence of micrometastases in bone marrow had a
statistically significant correiation with the histologic grade ofthe tumor and with the number
ofiymph node metastases. The presence of micrometastases in bone marrow identifies patients
with node nega tive disease who are at a risk for recurrence.

Downloads

Download data is not yet available.

References

1.COTE RJ, ROSEN P, LESSER M et al.

Prediction of early relapse in patients with

operable breast câncer by detection of

occult bone marrow disseminated tumor

cells. J Clin Oncol 1991; 9(10): 1749-56.

2.FROST P, LEWIN B. Clinicai implications

of metastatic process. Lancet 1992;

339: 1458-61.

3.SLOANE JP, ORMEROD MG, IMRIE

SF,COOMBES RC. The use of antisera to

epithelial membrane antigen in detection micrometastases in histological sections.

Br. J Câncer 1980; 42: 392-8.

4.PANTEL K, COTE RJ, FODSTAD O. Detection and clinicai importance of micrometastatic disease. J Natl Câncer

Inst 1999; 7;91(13): 1113-24.

5.PUTZ E, WITTER K, OFFNER S et a!

Phenotypic characteristics of cell lines

derived from disseminated câncer cells in

bone marrow of patients with solid

epithelial tumor: establishment of working models for human micrometastases.

Câncer Re 1999; 59: 241-8.

6.BRAUN S, KENTENICH C, JANNI W et al.

Lack of effect of adjuvant chemotherapy

on the elimination of single dormant

tumor cells in bone marrow of high-risk

breast câncer patients. J Clin Oncol

2000; 18(1): 80-6.

7.PANTEL K, CHLIMOK G, ANGSTWURM M

et al. Methodological analysis of

immunocytochemical screening for

disseminated epithelial tumor cells in

bone marrow. J Hematother 1994; 3(3):

165-73.

8.BRAUN S, PANTEL K, JANNI W et al.

Cytokeratin-positive cells in the bone marrow and survival of patients with

stage I, II or III breast câncer. N Engl J Med. 2000; 342: 525-33.

9.REDDING WH, COMBES RC, MONGHAN P

et a! Detection of micrometastases in

patients with primary breast câncer.

Lancet 1983; 2: 1271-4.

10.MOLINO AM, PELOSI G, TURAZZA M et

a! Bone marrow micrometastases in 109

breast câncer patients: correlations with

clinicai and pathological features and

prognosis. Breast Câncer Research and

Treatment 1997; 42: 23-30.

11.GUENTHER JM, HANSEN NM, DiFRONZO

LA et al. Axillary dissection is not

required for ali patients with breast

câncer and positive sentinel nodes. Arch

Surg 2003; 138(1): 52-6.

12.DIEL IJ, KAUFMANN M, COSTA SD, HOLLE R et al. Micrometastatic breast

câncer in bone marrow at primary

surgery: prognostic value in camparison with nodal status. J Natl Câncer Inst

1996; 88: 1652-64.

Published

2026-07-29

How to Cite

da-Silva, T. sollero claudio, Bizon, R., Nicola, M. H., Borojevic, R., & Costa, M. M. (2026). Detection of bone marrow micrometastases in patients with primaiy breast câncer: correlations with pTNM stage, age and histological grade. Mastology, 13(3). Retrieved from https://mastology.org/journal/article/view/2101

Issue

Section

Original Articles